title: Localization of brain 5α-reductase messenger RNA in mice selectively bred for high chronic alcohol withdrawal severity.
abstract: Several lines of evidence suggest that fluctuations in endogenous levels of the γ-aminobutyric acid (GABA)ergic neurosteroid allopregnanolone (ALLO) represent one mechanism for regulation of GABAergic inhibitory tone in the brain, with an ultimate impact on behavior. Consistent with this idea, there was an inverse relationship between ALLO levels and symptoms of anxiety and depression in humans and convulsive activity in rodents during alcohol withdrawal. Our recent studies examined the activity and expression of 5α-reductase (Srd5a1), the rate-limiting enzyme in the biosynthesis of ALLO, during alcohol withdrawal in mice selectively bred for high chronic alcohol withdrawal (Withdrawal Seizure-Prone [WSP]) and found that Srd5a1 was downregulated in the cortex and hippocampus over the time course of dependence and withdrawal. The purpose of the present studies was to extend these findings and more discretely map the regions of Srd5a1 expression in mouse brain using radioactive in situ hybridization in WSP mice that were ethanol naïve, following exposure to 72h ethanol vapor (dependent) or during peak withdrawal. In naïve animals, expression of Srd5a1 was widely distributed throughout the mouse brain, with highest expression in specific regions of the cerebral cortex, hippocampus, thalamus, hypothalamus, and amygdala. In dependent animals and during withdrawal, there was no change in Srd5a1 expression in cortex or hippocampus, which differed from our recent findings in dissected tissues. These results suggest that local Srd5a1 mRNA expression in WSP brain may not change in parallel with local ALLO content or withdrawal severity.
authors.affiliation: Department of Physiology and Pharmacology, Oregon Health & Science University, Portland, OR 97239, USA.
authors.forename: Charles E
authors.initials: CE
authors.lastname: Roselli
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Finn
authors.forename: Sean M
authors.initials: SM
authors.lastname: Ronnekleiv-Kelly
authors.forename: Michelle A
authors.initials: MA
authors.lastname: Tanchuck
authors.forename: Katherine R
authors.initials: KR
authors.lastname: Kaufman
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Finn
mesh_terms: D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Q000235:genetics / Q000378:metabolism; D000679:Amygdala / Q000201:enzymology; D000818:Animals; D001921:Brain / Q000201:enzymology*; D002540:Cerebral Cortex / Q000201:enzymology; D000431:Ethanol; D015870:Gene Expression; D006624:Hippocampus / Q000201:enzymology; D007031:Hypothalamus / Q000201:enzymology; D008297:Male; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism; D051379:Mice; D011280:Pregnanolone / Q000032:analysis / Q000096:biosynthesis; D012333:RNA, Messenger / Q000032:analysis*; D013375:Substance Withdrawal Syndrome / Q000201:enzymology / Q000235:genetics*; D013788:Thalamus / Q000201:enzymology
chemical_list: D008565:Membrane Proteins; D012333:RNA, Messenger; D000431:Ethanol; D011280:Pregnanolone; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase; C518406:Srd5a1 protein, mouse